PMID: 6167141Feb 1, 1981Paper

Studies on the mechanism of action of LS 1727, a nitrosocarbamate of 19-nortestosterone

Acta Pharmacologica Et Toxicologica
B Hartley-AspK R Harrap

Abstract

LS 1727, a nitrosocarbamate of 19-nortestosterone, was active against lymphoid, antimetabolite-sensitive, cell lines in vitro especially L1210 and Ehrlich ascites tumour lines. It was less effective against alkylating agent-sensitive lines such as the Walker 256 carcinosarcoma. These results suggested a possible antimetabolite mode of action but LS 1727 had no effect on deoxy-or ribonucleotide pool sizes in L1210 cells. Studies on macromolecular synthesis showed an early inhibition of DNA synthesis whilst RNA and protein synthesis continued for 24-48 hours. This was reminiscent of a classic alkylating agent-like effect. In vivo studies with specific alkylating agent-sensitive, or antimetabolite-sensitive tumours showed no antitumour activity although significant inhibition of Ehrlich ascites tumour cell growth was observed at high doses. In vitro cytotoxicity studies showed LS 1727 to be inactivated in the presence of mouse, rat and dog liver supernatants. This would explain the poor antitumour effects in vivo compared with the in vitro observations. Because LS 1727 is a nitrosocarbamate its possible mutagenic activity was investigated. LS 1727 was highly mutagenic but this property was also lost in the presence of a rat liver ...Continue Reading

References

Apr 1, 1979·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R BouvengJ Müntzing
Sep 1, 1975·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J CsetényiS Eckhardt
Apr 1, 1977·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L Brandt, I Könyves
Nov 1, 1977·Mutation Research·S VenittM Osborne
Dec 1, 1975·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·I KönyvesH Westerberg-Larsson
Feb 1, 1977·British Journal of Urology·R Nagel, C P Köllin
Aug 1, 1977·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K R HarrapI Konyves
Jan 1, 1976·Advances in Enzyme Regulation·K R Harrap, R M Paine
Apr 1, 1976·The Journal of Urology·A MittelmanG P Murphy
Feb 1, 1974·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L D EngelseW Misdorp
Nov 1, 1972·Chemico-biological Interactions·T A ConnorsM L Tobe
Feb 18, 1969·Biochimica Et Biophysica Acta·A W Solter, R E Handschumacher
Jul 15, 1970·International Journal of Cancer. Journal International Du Cancer·S S Mirvish, L Kaufman
May 1, 1968·Mutation Research·J Velemínský, T Gichner
Mar 1, 1969·British Journal of Cancer·D D LeaverP N Magee
Jul 1, 1966·The Journal of Pathology and Bacteriology·K M Herrold

❮ Previous
Next ❯

Citations

Jan 1, 1984·Journal of Cancer Research and Clinical Oncology·W J ZellerG Eisenbrand

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinosarcoma

Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. Discover the latest research on carcinosarcoma here.